NeuroSolutions is a contract research organisation established in 2001 as a service provider of cutting edge electrophysiological and behavioural research in the field of neuroscience.
NeuroSolutions also has considerable expertise in a number of other key areas of neuroscience, including particular experience in providing first class preclinical translational research into obesity and epilepsy.
Our broad track record is demonstrated through our manuscript publications and a key strength is in developing precisely tailored research packages to target out client’s needs.
Whether it’s using in vitro or in vivo electrophysiological approaches to investigate mechanism, whole animal behavior or molecular biology techniques to better understand function or side effect profiles, our research teams will provide expert consultancy in putting together the study proposal you require, and our investigators will then rapidly deliver data of the highest quality to drive forward your research programs.
Relevant NeuroSolutions Publications:
A Neural basis for Octanoic acid regulation of energy balance. Mol Metab. 2020 Apr;34:54-71.
The impact of ageing, fasting and high-fat diet on central and peripheral glucose tolerance and glucose-sensing neural networks in the arcuate nucleus. J Neuroendocrinol. 2017 Oct;29(10).
| Disease Areas | Behavioural Tests | Electrophysiological Assays |
|---|---|---|
|
Disease Areas
|
Behavioural Tests
|
Behavioural Tests
In vivo: single unit recordings from most characterised brain regions Local field potential/population spike recording from hippocampus/cortex In vitro: whole-cell patch-clamp recordings from brain slices (current/voltage/blind/visualised) Local field potentials – spontaneous and evoked extracellular recordings from brain slices Ion channel pharmacology: state-dependency, kinetics, and site of action using cultured and primary dissociated neurones, cell lines |
"Thank you for the absolutely phenomenal work you have done for Redpin. As biotech managers, we frequently push CROs to the max and sometimes take them for granted. After reviewing the work that you have done over the past year, I felt that I needed to let you know what a difference you had made to Redpin’s growth and success. Your work has been of the highest caliber and your dedication unmatched."
Elma Hawkins PhD, MBA, former President and CEO Redpin Therapeutics, Inc.
"I have worked with NeuroSolutions on many projects over many years. The quality of the data is second to none, their scientific expertise and collaborative approach to our technicality demanding projects has been excellent. For example, the work on SEN1576 has led to high-impact joint publications with Senexis and this compound is now being developed by Talisman Therapeutics.."
Dr Mark Treherne - As former Chief Executive of Senexis Limited (Dr Treherne is currently Chief Executive of Life Sciences Organisation at UK Trade & Investment, which helps UK business trade overseas).
Email: info@nsolns.com
Contact Head-office on +44 (0) 8454 500171
One of our partner companies may be better suited to your requirements